The global patent landscape of the drugs for treating Alzheimer’s disease from 2014–2023
Our findings highlight how AD patent landscapes integrate multiple scientific pathways and commercial strategies. The discrepancy between top patentees and top-cited inventions underscores the multifaceted nature of innovation in AD therapeutics. These insights, combined with broader scientific context, may guide policy decisions, R&D collaborations, and future research priorities in tackling this urgent healthcare challenge.
Authors
- Yuan Gao (ORCID: https://orcid.org/0000-0003-4779-9780)
- Yan Xu (ORCID: https://orcid.org/0000-0003-2857-4340)
Institutions
- Yangzhou Polytechnic Institute (CN)
- Northern University of Malaysia (MY)
Publication Details
- Journal
- BMC Neurology
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1186/s12883-025-04352-9
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00